The sole is a few millimetres of flat rubber, no heel to speak of, the toe box splayed wide enough to hold a fanned hand. From above it reads as almost nothing: a slip of mesh or nappa laid flat, the shape of the foot and little else. That emptiness has turned into luxury’s newest status marker: health-coded, un-hyped, nearly impossible to knock off. It is climbing from wellness forums onto the runways of Chanel, Dior and Louis Vuitton.

Vivobarefoot, the British label that has spent a decade insisting your shoes are ruining your feet, moved 1.2 million pairs last year on revenue of £91.4m, with unit sales up 12 percent. Its founder Galahad Clark, a defector from the Clarks dynasty, likes to say that “most modern shoes weaken people’s feet”, then sells the correction as a return to something evolutionary. The silhouette outgrew its niche fast. Chanel cut a barefoot-style shoe for its Cruise 2026/27 show in Biarritz; Dior’s Roadie, designed under Jonathan Anderson, rides a two-part sole built to bend with the foot; Louis Vuitton worked the silhouette into SS26.

None of this is new, which is worth settling before anyone calls it a trend. Anna Kalsø, a Danish yoga instructor, designed a “minus heel” shoe around 1957, the sole thinner under the heel than the toe so the wearer tilted back as if standing in wet sand. It reached New York in April 1970, weeks ahead of the first Earth Day, as the Kalsø Earth Shoe, sold on vague claimed health benefits, and became a status object of the granola class — expanding past a hundred stores before a bankruptcy filing left more than 140 franchisees without a supplier. The health claim was always the styling. What Kalsø grasped, and what Chanel grasps now, is that a shoe sold as good for the body carries a moral charge no logo can buy.

The timing is not an accident. The hype-sneaker economy that ran footwear for fifteen years is deflating: sportswear sales growth has slid from above 10 percent in 2022 to barely 1 percent in 2025, and resale is no longer the blanket amplifier it once was — a handful of names still climb while the loud, logo-driven releases mostly sit. A hype sneaker is engineered to be seen and therefore to be copied — a recognisable last, a colourway, a swoosh a dupe factory can trace by Friday. The barefoot flat gives the algorithm nothing to grab. It photographs as a bare foot, so its value lives in what you know rather than what you show: that the mesh upper is the costly kind, that a flat, foot-shaped sole now reads as care instead of cheapness.

A shoe that photographs as nothing gives the drop machine nothing to flip.

The withering footnote is that luxury took the silhouette and left the biomechanics behind. Houses borrow the flexible sole and the wide toe box while quietly dropping the zero-drop, no-cushioning definition that health-focused makers are still fighting to formalise, so the “health” in health-coding is mostly costume. The posture correction is optional; the moral posture is the product. Kalsø sold the granola class a shoe that promised to fix the way they walked. What Chanel sells a richer class is subtler: a shoe that promises nothing you can see, which this season is the most expensive promise a shoe can make.